NasdaqGS - Nasdaq Real Time Price USD

GE HealthCare Technologies Inc. (GEHC)

Compare
89.91 -0.71 (-0.78%)
As of 10:13 AM EDT. Market Open.
Loading Chart for GEHC
DELL
  • Previous Close 90.62
  • Open 90.35
  • Bid 89.83 x 300
  • Ask 90.02 x 300
  • Day's Range 89.60 - 90.66
  • 52 Week Range 62.35 - 94.50
  • Volume 602,456
  • Avg. Volume 2,646,596
  • Market Cap (intraday) 41.058B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 25.99
  • EPS (TTM) 3.46
  • Earnings Date Jul 31, 2024
  • Forward Dividend & Yield 0.12 (0.13%)
  • Ex-Dividend Date Oct 18, 2024
  • 1y Target Est 94.89

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

www.gehealthcare.com

51,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GEHC

View More

Performance Overview: GEHC

Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GEHC
16.41%
S&P 500
19.26%

1-Year Return

GEHC
36.19%
S&P 500
28.00%

3-Year Return

GEHC
42.71%
S&P 500
46.01%

5-Year Return

GEHC
42.71%
S&P 500
46.01%

Compare To: GEHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GEHC

View More

Valuation Measures

Annual
As of 9/19/2024
  • Market Cap

    41.38B

  • Enterprise Value

    49.05B

  • Trailing P/E

    26.19

  • Forward P/E

    19.27

  • PEG Ratio (5yr expected)

    2.35

  • Price/Sales (ttm)

    2.13

  • Price/Book (mrq)

    5.30

  • Enterprise Value/Revenue

    2.51

  • Enterprise Value/EBITDA

    14.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.09%

  • Return on Assets (ttm)

    5.73%

  • Return on Equity (ttm)

    21.22%

  • Revenue (ttm)

    19.52B

  • Net Income Avi to Common (ttm)

    1.58B

  • Diluted EPS (ttm)

    3.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2B

  • Total Debt/Equity (mrq)

    120.87%

  • Levered Free Cash Flow (ttm)

    1.96B

Research Analysis: GEHC

View More

Company Insights: GEHC

Research Reports: GEHC

View More

People Also Watch